Bonyf N.V. Logo

Bonyf N.V.

Develops medical devices for oral, dental, orthodontic, and dermatological care.

MLBON | BR

Overview

Corporate Details

ISIN(s):
BE6333353298
LEI:
699400NGN0HE0QBIF505
Country:
Belgium
Address:
Doornzelestraat 114 bus D, 9000 Gent

Description

Bonyf N.V. is a company specializing in the research, development, production, and distribution of products for oral, dental, orthodontic, and dermatological care. The company develops clinically validated solutions for dental professionals, pharmacies, and consumers. Its portfolio includes care products for removable oral appliances such as dentures, retainers, and orthodontic devices. Key innovations are based on its patented NitrAdine® formulation, which is used in products like disinfecting tablets and PerioCream, a mucoadhesive paste for professional periodontal treatment. Bonyf focuses on providing high-quality, certified medical device solutions to improve patient well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 15:23
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
English 19.5 KB
2025-09-15 17:28
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Dusseldorf
English 16.3 KB
2025-09-05 10:51
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developm…
English 15.3 KB
2025-08-11 15:16
Periocream: The Future Commercial Winner for bonyf
English 17.8 KB
2025-07-14 17:43
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
English 21.7 KB
2025-06-30 21:18
Annual Results 2024
English 12.4 KB

Automate Your Workflow. Get a real-time feed of all Bonyf N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonyf N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonyf N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-12-16 Bogaert Jean-Pierre Executive member Sell 1,096 20,824.00 EUR
2024-12-06 Bogaert Jean-Pierre Executive member Sell 2,300 41,400.00 EUR
2024-11-29 Bogaert Jean-Pierre Executive member Sell 913 16,454.30 EUR
2024-11-28 Bogaert Jean-Pierre Executive member Sell 1,289 23,330.90 EUR
2024-11-26 Bogaert Jean-Pierre Executive member Sell 390 7,059.00 EUR
2024-11-25 Bogaert Jean-Pierre Executive member Sell 1,020 18,267.00 EUR
2024-11-22 Bogaert Jean-Pierre Executive member Sell 1,375 23,822.50 EUR
2024-11-15 Bogaert Jean-Pierre Executive member Sell 531 8,336.70 EUR
2024-11-06 Bogaert Jean-Pierre Executive member Sell 682 10,775.60 EUR
2024-10-31 Bogaert Jean-Pierre Executive member Sell 210 3,318.00 EUR

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.